133 related articles for article (PubMed ID: 1812289)
41. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
Bresgen M; Weller M; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
[TBL] [Abstract][Full Text] [Related]
42. Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy.
Kobayashi Y; Yoshida S; Zhou Y; Nakama T; Ishikawa K; Arima M; Nakao S; Sassa Y; Takeda A; Hisatomi T; Ikeda Y; Matsuda A; Sonoda KH; Ishibashi T
Mol Vis; 2016; 22():436-45. PubMed ID: 27186070
[TBL] [Abstract][Full Text] [Related]
43. Localization of acidic fibroblast growth factor in proliferative vitreoretinopathy membranes.
Malecaze F; Mathis A; Arné JL; Raulais D; Courtois Y; Hicks D
Curr Eye Res; 1991 Aug; 10(8):719-29. PubMed ID: 1717200
[TBL] [Abstract][Full Text] [Related]
44. Inflammatory cells in proliferative vitreoretinopathy subretinal membranes.
Charteris DG; Hiscott P; Robey HL; Gregor ZJ; Lightman SL; Grierson I
Ophthalmology; 1993 Jan; 100(1):43-6. PubMed ID: 8094546
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical localization of epidermal growth factor receptor in a human epiretinal membrane.
Heidenkummer HP; Kampik A
Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):492-6. PubMed ID: 1718825
[TBL] [Abstract][Full Text] [Related]
46. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
47. Class II histocompatibility antigen expression by cellular components of vitreous and subretinal fluid in proliferative vitreoretinopathy.
Baudouin C; Brignole F; Bayle J; Fredj-Reygrobellet D; Lapalus P; Gastaud P
Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):2065-72. PubMed ID: 2055699
[TBL] [Abstract][Full Text] [Related]
48. Localisation of opticin in human proliferative retinal disease.
Pattwell DM; Sheridan CM; Le Goff M; Bishop PN; Hiscott P
Exp Eye Res; 2010 Mar; 90(3):461-4. PubMed ID: 20036236
[TBL] [Abstract][Full Text] [Related]
49. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy.
Johnsen EO; Frøen RC; Albert R; Omdal BK; Sarang Z; Berta A; Nicolaissen B; Petrovski G; Moe MC
Exp Eye Res; 2012 May; 98():28-36. PubMed ID: 22465407
[TBL] [Abstract][Full Text] [Related]
50. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
51. Cellular components of subretinal membranes in proliferative vitreoretinopathy.
Hiscott P; Morino I; Alexander R; Grierson I; Gregor Z
Eye (Lond); 1989; 3 ( Pt 5)():606-10. PubMed ID: 2483551
[TBL] [Abstract][Full Text] [Related]
52. Expression of growth factor mRNA in rabbit PVR model systems.
Planck SR; Andresevic J; Chen JC; Holmes DL; Rodden W; Westra I; Wu SC; Huang XN; Kay G; Wilson DJ
Curr Eye Res; 1992 Nov; 11(11):1031-9. PubMed ID: 1282856
[TBL] [Abstract][Full Text] [Related]
53. Myeloid-Related Protein-14/MRP-14/S100A9/Calgranulin B is Associated with Inflammation in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Alam K; Siddiquei MM; Van den Eynde K; Mohammad G; De Hertogh G; Opdenakker G
Ocul Immunol Inflamm; 2018; 26(4):615-624. PubMed ID: 27849448
[TBL] [Abstract][Full Text] [Related]
54. Cell components in proliferative vitreoretinopathy: immunofluorescent double staining of cultured cells from proliferative tissues.
Shirakawa H; Yoshimura N; Yamakawa R; Matsumura M; Okada M; Ogino N
Ophthalmologica; 1987; 194(1):56-62. PubMed ID: 2438620
[TBL] [Abstract][Full Text] [Related]
55. Quantitative assessment of growth stimulating activity of the vitreous during PVR.
Yang CM; Cousins SW
Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2436-42. PubMed ID: 1634341
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin.
Kobayashi Y; Yoshida S; Nakama T; Zhou Y; Ishikawa K; Arita R; Nakao S; Miyazaki M; Sassa Y; Oshima Y; Izuhara K; Kono T; Ishibashi T
Br J Ophthalmol; 2015 Apr; 99(4):451-6. PubMed ID: 25281471
[TBL] [Abstract][Full Text] [Related]
57. Variation in epiretinal membrane components with clinical duration of the proliferative tissue.
Morino I; Hiscott P; McKechnie N; Grierson I
Br J Ophthalmol; 1990 Jul; 74(7):393-9. PubMed ID: 2378854
[TBL] [Abstract][Full Text] [Related]
58. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
59. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
60. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
